Who's News:
   Circadian's Founder
   Resigns as Company
   Posts 2nd-Period Loss
The maker of diagnostic medical products reported a loss
of $215,000, or five cents a share, compared with net income
of $30,000, or one cent a share, in the year-earlier quarter.
Sales fell 3% to $3.6 million from $3.7 million.
Shareholders' equity is $428,000, down from nearly $7 million
two years ago.
   The company said no replacement has been named for Mr.
Rammler. Peter Chang remains as president and chief executive
officer.
   In over-the-counter trading yesterday, Circadian shares
were quoted at 37.5 cents bid.